Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma

BMC cancer, Volume 16, Issue 1, 2016, Pages 464

Cited by: 0|Bibtex|Views4|Links
WOS
Keywords:
Paclitaxel Maximum Tolerate Dose Dose Cohort Granulocyte Colony Stimulate Factor Treatment Metastatic Nasopharyngeal Carcinoma

Abstract:

ClinicalTrials.gov ID: NCT01735409 . The trial was registered on November 20th, 2012.

Code:

Data:

Your rating :
0

 

Tags
Comments